[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing",
    "summary": "Amgen (AMGN) concluded the recent trading session at $311.55, signifying a +1.5% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=b0a364ba6bee873340f902350d7509fb0e4322e2e929d5e14266bd46254cdae2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743458415,
      "headline": "Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing",
      "id": 133633050,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) concluded the recent trading session at $311.55, signifying a +1.5% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=b0a364ba6bee873340f902350d7509fb0e4322e2e929d5e14266bd46254cdae2"
    }
  },
  {
    "ts": null,
    "headline": "RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar",
    "summary": "Dr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.",
    "url": "https://finnhub.io/api/news?id=2773ab609e61ad22906a0206ba8fbb465ae5eb55308723b21508b88063cb85c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743427800,
      "headline": "RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar",
      "id": 133627790,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Dr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.",
      "url": "https://finnhub.io/api/news?id=2773ab609e61ad22906a0206ba8fbb465ae5eb55308723b21508b88063cb85c5"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 113-point rally led by gains for shares of Amgen, IBM",
    "summary": "Dow's 113-point rally led by gains for shares of Amgen, IBM",
    "url": "https://finnhub.io/api/news?id=b1fb324310d32eea420b654186992bd8c2d3679e66c43181f1bbace1b43b05e5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743421260,
      "headline": "Dow's 113-point rally led by gains for shares of Amgen, IBM",
      "id": 133635908,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow's 113-point rally led by gains for shares of Amgen, IBM",
      "url": "https://finnhub.io/api/news?id=b1fb324310d32eea420b654186992bd8c2d3679e66c43181f1bbace1b43b05e5"
    }
  },
  {
    "ts": null,
    "headline": "Amgen: Excellent Buy And Hold For A Volatile Market",
    "summary": "Amgen: Excellent Buy And Hold For A Volatile Market",
    "url": "https://finnhub.io/api/news?id=b6d643e1c4e21bfac29ba203376af3f793fb7d80465b59acc84050d17347b3e1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743408000,
      "headline": "Amgen: Excellent Buy And Hold For A Volatile Market",
      "id": 133625373,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b6d643e1c4e21bfac29ba203376af3f793fb7d80465b59acc84050d17347b3e1"
    }
  }
]